Mahinay, Baby Girl .

HRN: 23-95-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/23/2023
10/29/2023
IVT
30mg
Q24
Prophylaxis
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  PneumoniaProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: